Literature DB >> 26688532

Tuberculosis screening outcomes for newly diagnosed persons living with HIV, Nyanza Province, Kenya, 2009.

B Burmen1, S Modi2, J S Cavanaugh2, H Muttai3, K D McCarthy2, H Alexander2, K Cain4.   

Abstract

SETTING: Fifteen human immunodeficiency virus (HIV) clinics in Nyanza Region, Western Kenya.
OBJECTIVE: To describe routine tuberculosis (TB) screening and diagnostic practices among newly enrolled people living with HIV (PLHIV) prior to the implementation of World Health Organization recommended TB intensified case finding.
DESIGN: Retrospective chart abstraction of PLHIV aged ⩾7 years who were newly enrolled in HIV care in July and August 2009, and who had not received antiretroviral treatment in the preceding 2 years or been diagnosed with TB in the previous year. Factors associated with evidence of TB diagnostic evaluation among symptomatic PLHIV were assessed.
RESULTS: Of 1020 patients included in the analysis, 995 (98%) were screened for TB at enrolment and 613 (62%) reported TB symptoms. Ninety-six (16%) patients with symptoms had evidence of referral for TB diagnostic evaluation, including patients at large clinics, those with advanced HIV disease and those reporting multiple TB symptoms. Among the 43 (45%) with documented evaluation results, 26 (60%) were diagnosed with TB.
CONCLUSION: Although most PLHIV were screened for TB, very few underwent an evaluation, and the proportion diagnosed with TB was very low. Efforts to improve TB screening should focus on standardizing the intensified case finding algorithm and linkage to, and adequate infrastructure for, TB diagnostic evaluation.

Entities:  

Mesh:

Year:  2016        PMID: 26688532      PMCID: PMC5055834          DOI: 10.5588/ijtld.15.0053

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  17 in total

1.  Progress towards improved tuberculosis diagnostics for developing countries.

Authors:  Mark D Perkins; Giorgio Roscigno; Alimuddin Zumla
Journal:  Lancet       Date:  2006-03-18       Impact factor: 79.321

2.  Diagnostic management and outcomes of pulmonary tuberculosis suspects admitted to a central hospital in Malawi.

Authors:  L G Gawa; T Reid; M E Edginton; M Van Lettow; M Joshua; A D Harries
Journal:  Public Health Action       Date:  2011-09-21

3.  Impact of empiric antibiotics and chest radiograph on delays in the diagnosis of tuberculosis.

Authors:  J E Golub; S Bur; W A Cronin; S Gange; T R Sterling; B Oden; N Baruch; G W Comstock; R E Chaisson
Journal:  Int J Tuberc Lung Dis       Date:  2005-04       Impact factor: 2.373

4.  Is the delay in diagnosis of pulmonary tuberculosis related to exposure to fluoroquinolones or any antibiotic?

Authors:  M Wang; J M Fitzgerald; K Richardson; C A Marra; V J Cook; J Hajek; R K Elwood; W R Bowie; F Marra
Journal:  Int J Tuberc Lung Dis       Date:  2011-08       Impact factor: 2.373

5.  TB diagnostic process management of patients in a referral hospital in Mozambique in comparison with the 2007 WHO recommendations for the diagnosis of smear-negative pulmonary TB and extrapulmonary TB.

Authors:  Jeannet C Bos; Lisette Smalbraak; Augusto C Macome; Ermelinda Gomes; Frank van Leth; Jan M Prins
Journal:  Int Health       Date:  2013-10-14       Impact factor: 2.473

6.  Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.

Authors:  Ankur Gupta; Robin Wood; Richard Kaplan; Linda-Gail Bekker; Stephen D Lawn
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

7.  Missed opportunities in TB diagnosis: a TB process-based performance review tool to evaluate and improve clinical care.

Authors:  Nigel Field; Jill Murray; Michelle L Wong; Rob Dowdeswell; Ntomboxolo Dudumayo; Lesego Rametsi; Neil Martinson; Marc Lipman; Judith R Glynn; Pam Sonnenberg
Journal:  BMC Public Health       Date:  2011-02-22       Impact factor: 3.295

8.  Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.

Authors:  Stephen D Lawn; Sophie V Brooks; Katharina Kranzer; Mark P Nicol; Andrew Whitelaw; Monica Vogt; Linda-Gail Bekker; Robin Wood
Journal:  PLoS Med       Date:  2011-07-26       Impact factor: 11.069

9.  Purposeful selection of variables in logistic regression.

Authors:  Zoran Bursac; C Heath Gauss; David Keith Williams; David W Hosmer
Journal:  Source Code Biol Med       Date:  2008-12-16

10.  Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.

Authors:  Taye T Balcha; Erik Sturegård; Niclas Winqvist; Sten Skogmar; Anton Reepalu; Zelalem Habtamu Jemal; Gudeta Tibesso; Thomas Schön; Per Björkman
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more
  3 in total

1.  C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa.

Authors:  Adrienne E Shapiro; Ting Hong; Sabina Govere; Hilary Thulare; Mahomed-Yunus Moosa; Afton Dorasamy; Carole L Wallis; Connie L Celum; Jacques Grosset; Paul K Drain
Journal:  AIDS       Date:  2018-08-24       Impact factor: 4.177

2.  The Use of Laypersons to Support Tuberculosis Screening at a Kenyan Referral Hospital.

Authors:  Barbara Kabai Burmen; Joseph Mogunde; Timothy Malika
Journal:  Int J Prev Med       Date:  2018-05-16

3.  Tuberculosis among individuals with community-acquired pneumonia presenting to emergency in Gaborone, Botswana.

Authors:  Jill K Gersh; Zachary Feldman; Emily Greenberger; Amit Chandra; Harvey M Friedman; Ari Ho-Foster; Michelle K Haas
Journal:  J Public Health Afr       Date:  2018-05-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.